Ruian Ke

Staff Scientist, Los Alamos National Laboratory

[Ruian Ke @ke_lab]

Quantifying the rate and magnitude of the Omicron outbreak in China after sudden exit from ‘zero-COVID’ restrictions https://t.co/N7TvewFY7W

[Koelle Lab @KoelleLab]

Our review on what we’ve learned about SARS-CoV-2 epidemiology and what questions remain to be answered is out today in @ScienceMagazine! Written with @m_a_martin R.Antia @B_Lopman and @nataliexdean https://t.co/ODwUqJLMzs

[VignuzziLab @VignuzziLab]

As announced in yesterday's seminar, @VignuzziLab is packing up its pipettes and taking on a new continent! As of September 2022, Vignuzzi Lab Asia will open its doors at A*Star Infectious Disease Labs in beautiful Singapore!

[SHIELD Illinois COVID Testing @SHIELDIllinois]

More experts agree with @UofIllinois' @_chris_brooke and @rlsdvm_epivet that saliva samples catch COVID-19 virus earlier than nasal. That's one of the reasons why our covidSHIELD test identifies positives & can help slow virus spread. https://t.co/2h93uCwxRy

[Benjamin tenOever @virusninja]

My hypothesis: #Omicron Spike binds ACE2 so well, infections start exclusively in the upper airways. Cell death and debris from those initial infections induce interferon in the lungs, providing greater protection than seen for other VOCs. Still can be a dangerous virus though.

[VignuzziLab @VignuzziLab]

how did I miss this? either you didn't post it @_chris_brooke man of the year, or I missed it, but i'm gonna resurrect it here:

[Fadi Alnaji @biofadialnaji]

Our latest @_chris_brooke lab in collaboration with @aj_velthuis is now peer reviewed and published. https://t.co/dDlyNUoK6d

[NIH @NIH]

News: NIH-funded screening study builds case for frequent COVID-19 antigen testing https://t.co/Fw0PZFNR7a

[Genomic Biology @IGBIllinois]

This Thursday at 6 pm, @_chris_brooke will be a moderator for the town hall. Ask the experts about the COVID-19 vaccines! Register at https://t.co/mVz7Yp976A.

[Fadi Alnaji @biofadialnaji]

Our latest at @_chris_brooke lab in collaboration with @aj_velthuis on the formation and packaging mechanism of Influenza A Virus (IAV) defective interfering particles https://t.co/W27waIxpv8

[Amber Smith, PhD @mathematista]

I’m so exited and honored to join @PLOSCompBiol 🎉

[PLOS Comp Biol @PLOSCompBiol]

Meet our new Associate Editor, Amber Smith! @mathematista says: "I love the high quality, high impact work published in PLOS Comp Bio, and I’m excited to help facilitate top-notch mathematical biology research." Find out more here: https://t.co/42zyHZCcPM

[medRxiv @medrxivpreprint]

Estimating the strength of selection for new SARS-CoV-2 variants https://t.co/cX2TIk9OEj #medRxiv

[Koelle Lab @KoelleLab]

tl;dr we estimate that 99% of successful transmissions are expected to result from 3 or fewer virions in natural human infection

[Koelle Lab @KoelleLab]

Our latest preprint, which revises the SARS CoV-2 transmission bottleneck estimates presented in Popa & Genger et al. 2020, is up today https://t.co/WNyG5WkmPl

[Joshua Weitz @joshuasweitz]

Upcoming @EmoryTMLS workshop on #Covid19 Modeling and Lessons Learned, 1/21, 10am-2pm EST.

Open to all, organized by @KatiaKoelle, @dbweissman and #RustomAntia, see image for speakers.

Streaming: https://t.co/J051b7b3LT

Register: https://t.co/hZmFuESCnn

[Laura Fabris @laurafabris77]

Thank you for the opportunity to share our work, part of a great collaboration with @_chris_brooke @thechanglab @ke_lab @KatiaKoelle funded by the @DARPA INTERCEPT program!

[Marc Lipsitch @mlipsitch]

Fascinating and high-tech investigation of a fishing vessel COVID outbreak https://t.co/Yif0LkAF1x with hints of seroprotection, and extremely high attack rate ~85%. Two critical findings at least, from well-done outbreak epidemiology. T cells didn't protect them from infection.

[medRxiv @medrxivpreprint]

Estimating the reproductive number R0 of SARS-CoV-2 in the United States and eight European countries and implications for vaccination https://t.co/N3L3DqNyaE #medRxiv

[Nicholas Wu @wchnicholas]

A very nicely written summary on what is known about influenza virus defective interfering particles and where the field is heading. Great title as well. By @biofadialnaji & @_chris_brooke
https://t.co/lHbsjkJTNR